Combined Lowering Effects of Rosuvastatin and L. acidophilus on Cholesterol Levels in Rat = Combined Lowering Effects of Rosuvastatin and L. acidophilus on Cholesterol Levels in Rat

다국어 초록 (Multilingual Abstract)

Statins are a class of lipid-lowering drugs commonly used in the prevention of cardiovascular diseases. However, statin therapy presents many limitations, which have led to an increased interest in non-drug therapies, such as probiotics, to improve blood cholesterol levels. Indeed, probiotic strains such as Lactobacillus acidophilus have been found to improve blood lipid profiles, especially in reducing total cholesterol and LDL-C levels. In this study, we established a high-cholesterol rat model and studied the effect of Lactobacillus acidophilus administration alone or in combination with rosuvastatin. We were able to show that Lactobacillus exerts a cholesterol-lowering effect. Additionally, we observed that when administered together, rosuvastin and Lactobacillus exert a combined cholesterol-lowering effect. Altogether, our data advocate for the possibility of establishing probiotics as non-drug supplements for the treatment of hypercholesterolemia.

참고문헌 (Reference)

1 Hollaender PL, "Whole-grain and blood lipid changes in apparently healthy adults : a systematic review and meta-analysis of randomized controlled studies" 102 : 556-572, 2015

2 Biagi E, "Through ageing, and beyond : gut microbiota and inflammatory status in seniors and centenarians" 5 : e10667-, 2010

3 Yasuda SU, "The role of ethnicity in variability in response to drugs: focus on clinical pharmacology studies" 84 : 417-423, 2008

4 Huang Y, "The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells" 103 : 473-478, 2010

5 Bahekar AA, "The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis" 154 : 830-837, 2007

6 Karamese M, "The immunostimulatory effect of lactic acid bacteria in a rat model" 13 : 220-228, 2016

7 Huang Y, "The hypocholesterolaemic effects of Lactobacillus acidophilus American type culture collection 4356 in rats are mediated by the down-regulation of Niemann-Pick C1-like 1" 104 : 807-812, 2010

8 Wang IK, "The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients : a randomised, double-blind, placebo-controlled trial" 6 : 423-430, 2015

9 Holecki M, "The decreased achievement of therapeutic goal in lipid lowering therapy in obese and diabetic patients in Poland" 69 : 6-12, 2017

10 Stone NJ, "The New Cholesterol Treatment Guidelines" 370 : 1957-, 2014

11 Wang P, "Statin dose in Asians: is pharmacogenetics relevant?" 12 : 1605-1615, 2011

12 Keys A, "Serum cholesterol response to dietary cholesterol" 40 : 351-359, 1984

13 Liu Y, "Selection of cholesterol-lowering lactic acid bacteria and its effects on rats fed with high-cholesterol diet" 74 : 623-631, 2017

14 Wilson MD, "Review of cholesterol absorption with emphasis on dietary and biliary cholesterol" 35 : 943-955, 1994

15 Zhao MM, "Regulation of organic anion transporting polypeptides expression and activity" 50 : 400-405, 2015

16 Le Vee M, "Regulation of drug transporter expression by oncostatin M in human hepatocytes" 82 : 304-311, 2011

17 Caporaso JG, "QIIME allows analysis of high-throughput community sequencing data" 7 : 335-336, 2010

18 Valerio MG, "Promising new therapies for the treatment of hypercholesterolemia" 16 : 609-618, 2016

19 Gerhard D, "Probiotic therapy reduces inflammation and improves intestinal morphology in rats with induced oral mucositis" 31 : e71-, 2017

20 Zheng Y, "Probiotic properties of Lactobacillus strains isolated from Tibetan kefir grains" 8 : e69868-, 2013

21 Kunze A, "Prediction of organic anion-transporting polypeptide 1B1-and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data" 42 : 1514-1521, 2014

22 Gylling H, "Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease" 232 : 346-360, 2014

23 Tung YC, "Piceatannol exerts anti-obesity effects in C57BL/6mice through modulating adipogenic proteins and gut microbiota" 21 : 2016

24 Wang Q, "Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy" 73 : 5261-5267, 2007

25 Kato T, "Multiple omics uncovers host-gut microbial mutualism during prebiotic fructooligosaccharide supplementation" 21 : 469-480, 2014

26 Shimizu M, "Meta-analysis : effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals" 10 : e0139795-, 2015

27 Chodick G, "Long-term persistence with statin treatment in a not-for-profit health maintenance organization : a population-based retrospective cohort study in Israel" 30 : 2167-2179, 2008

28 Russo M, "Lactobacillus fermentum CRL1446ameliorates oxidative and metabolic parameters by increasing intestinal feruloyl esterase activity and modulating microbiota in caloric-restricted mice" 8 : 2016

29 Huang Y, "Lactobacillus acidophilus ATCC 4356 prevents atherosclerosis via inhibition of intestinal cholesterol absorption in apolipoprotein E-knockout mice" 80 : 7496-7504, 2014

30 "Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model" 10 : 126-, 2011

31 Kelley GA, "Impact of progressive resistance training on lipids and lipoproteins in adults : another look at a meta-analysis using prediction intervals" 49 : 473-475, 2009

32 Rudling M, "Hepatic mRNA levels for the LDL receptor and HMG-CoA reductase show coordinate regulation in vivo" 33 : 493-501, 1992

33 Fukushima M, "Hepatic LDL receptor mRNA in rats is increased by dietary mushroom(Agaricus bisporus)fiber and sugar beet fiber" 130 : 2151-2156, 2000

34 Catry E, "Ezetimibe and simvastatin modulate gut microbiota and expression of genes related to cholesterol metabolism" 132 : 77-84, 2015

35 Shaw K, "Exercise for overweight or obesity, Cochrane Database Syst" 4 : CD003817-, 2006

36 Huffman KM, "Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I" 164 : 117-124, 2012

37 Teh SS, "Evaluation of agrowastes as immobilizers for probiotics in soy milk" 57 : 10187-10198, 2009

38 Dattilo AM, "Effects of weight reduction on blood lipids and lipoproteins : a meta-analysis" 56 : 320-328, 1992

39 Xie N, "Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet" 11 : 53-, 2011

40 Yu-Poth S, "Effects of the national cholesterol education program’s step I and step II dietary intervention programs on cardiovascular disease risk factors : a metaanalysis" 69 : 632-646, 1999

41 Fei L, "Effects of rosuvastatin and MiR-126 on myocardial injury induced by acute myocardial infarction in rats : role of vascular endothelial growth factor A(VEGF-A)" 22 : 2324-2334, 2016

42 Guglielmi V, "Effectiveness of adherence to lipid lowering therapy on LDL-cholesterol in patients with very high cardiovascular risk: a real-world evidence study in primary care" 263 : 36-41, 2017

43 Ejtahed H S, "Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus" 94 : 3288-3294, 2011

44 Jasso-Padilla I, "Effect of prebiotics of Agave salmiana fed to healthy Wistar rats" 97 : 556-563, 2017

45 Tomaro-Duchesneau C, "Effect of orally administered L, fermentum NCIMB 5221 on markers of metabolic syndrome:an in vivo analysis using ZDF rats" 98 : 115-126, 2014

46 Naruszewicz M, "Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers" 76 : 1249-1255, 2002

47 PARK, YOO HEON, "Effect of Dietary Inclusion of Lactobacillus acidophilus ATCC 43121 onCholesterol Metabolism in Rats" 한국미생물·생명공학회 17 (17): 655-662, 2007

48 Kotseva K, "EUROASPIRE IV : a european society of cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24european countries" 23 : 636-648, 2016

49 Martinez I, "Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota" 75 : 4175-4184, 2009

50 Cosin Sales J, "Cost-effectiveness of rosuvastatin versus simvastatin, atorvastatin and pitavastatin in patients with high and very high cardiovascular risk in Spain" 27 : 228-238, 2015

51 Brown L, "Cholesterol-lowering effects of dietary fiber : a meta-analysis" 69 : 30-42, 1999

52 Townsend N, "Cardiovascular disease in Europe 2015 : epidemiological update" 36 : 2673-2674, 2015

53 Cardiometabolic Risk Working Group, "Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group" 27 : e1-e33, 2011

54 Begley M, "Bile salt hydrolase activity in probiotics" 72 : 1729-1738, 2006

55 Parks DJ, "Bile acids : natural ligands for an orphan nuclear receptor" 284 : 1365-1368, 1999

56 Gilliland SE, "Assimilation of cholesterol by Lactobacillus acidophilus" 49 : 377-381, 1985

57 McDonald D, "An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea" 6 : 610-618, 2012

58 Consonni A, "Administration of bifidobacterium and lactobacillus strains modulates experimental myasthenia gravis and experimental encephalomyelitis in Lewis rats" 9 : 22269-22287, 2018

59 Liong MT, "Acid and bile tolerance and cholesterol removal ability of lactobacilli strains" 88 : 55-66, 2005

60 Musa-Veloso K, "A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range : results of a meta-analysis of randomized, placebocontrolled trials" 85 : 9-28, 2011

61 Catapano AL, "2016 ESC/EAS Guidelines for the Management of Dyslipidaemias" 74 : 1234-1318, 2016

62 Eckel RH, "2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk : a report of the American college of cardiology/American heart association task force on practice guidelines" 63 : 2960-2984, 2014